Skip to content

An Intervention Study on Transcranial Photobiomodulation in Children with Attention Deficit Hyperactivity Disorder

Intervention Study of Photon Therapy Device in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122490
Enrollment
Unknown
Registered
2026-04-14
Start date
2024-12-16
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder

Interventions

True - false stimulus group:First apply real stimulation and then fake stimulation, with an interval of at least one week. During true stimulation, the subjects will receive one tPBM intervention (las
False - true stimulus group:False stimulation followed by true stimulation at least one week apart. During true stimulation, the subject will receive a TPBM intervention (12-minute, 80MW/CM^2), during

Sponsors

Qilu Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1.Age: 12-18 years old; 2. Clinically diagnosed with ADHD by a pediatrician or child health care physician; 3. Confirmed by a pediatrician or child health care physician that it complies with the internationally recognized Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (5) Diagnostic criteria for attention deficit/hyperactivity impulse disorder in DSM-5 4.SNAP-IV score >=1.6; 5. It can be combined with transcranial photobiological regulation.

Exclusion criteria

Exclusion criteria: 1. It is in line with the diagnosis of other serious mental disorders, such as schizophrenia and bipolar disorder, etc. 2. There are serious physical diseases and conditions, such as significant intracranial lesions, thyroid diseases, epilepsy, and congenital heart disease Diseases, severe hematological disorders, systemic lupus erythematosus, visual and auditory impairments, etc. 3. Imaging examinations show obvious abnormalities in brain structure; 4. There is a serious neurological disorder, with a clear family history or potential risks; 5. There are metal or pacemaker implants in the body, or there are holes or cracks in the skull; 6. Currently undergoing other ADHD treatment methods (such as drug therapy like methylphenidate, behavioral therapy and other intervention measures).

Design outcomes

Primary

MeasureTime frame
Behavioral metrics for complex version tasks of CPT;

Secondary

MeasureTime frame
Analysis of the electroencephalogram (EEG) components N2pc and alpha spectrum of the complex version of CPT tasks;Results of cognitive behavioral tasks (reaction time and accuracy rate);Behavioral tasks involve three components of executive function: novelty (spatial nback, emotional nback and keep track), interference suppression (stroop, flanker and go nogo), and cognitive flexibility (local-global, circle and triangle, and DCCS).;Adhd-related symptom indicators (such as snap-IV scores, etc.).;

Countries

China

Contacts

Public ContactCao Aihua

Qilu Hospital of Shandong University

xinercah@163.com+86 18560086317

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026